SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-072048
Filing Date
2024-03-20
Accepted
2024-03-20 07:11:55
Documents
15
Period of Report
2024-03-20
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d812029d8k.htm   iXBRL 8-K 25501
2 EX-99.1 d812029dex991.htm EX-99.1 15964
6 GRAPHIC g812029g0320024612707.jpg GRAPHIC 2863
  Complete submission text file 0001193125-24-072048.txt   178019

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA caba-20240320.xsd EX-101.SCH 2866
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE caba-20240320_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE caba-20240320_pre.xml EX-101.PRE 11718
18 EXTRACTED XBRL INSTANCE DOCUMENT d812029d8k_htm.xml XML 3767
Mailing Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104
Business Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 (267) 759-3100
Cabaletta Bio, Inc. (Filer) CIK: 0001759138 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39103 | Film No.: 24766272
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)